Checkpoint Therapeutics Announces Encouraging Safety and Efficacy Data from Phase 1/2 Clinical Trial of EGFR Inhibitor CK-101
Golconda Gold Releases Q1 2026 Production Update and Announces Record Quarterly Production at the Galaxy Gold Mine